tirzepatide lily FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Eli Lily and Company's Zepbound

Improves Cardiovascular Health: Oceania Research suggests it may help lower blood pressure and reduce oxidative stress and heart disease risk by promoting relaxation and stress relief (12)

According to a recent review (297), clinical limitations often include heterogeneity of probiotic strains, large dose variability, and limited follow-up

Nausea, vomiting, and diarrhea are the predictable result in a large subset of users, and fluid loss from these GI effects is what produces dehydration

A review in the journal Molecules highlighted that liposomal delivery significantly boosts the bioavailability of glutathione

Insert the needle through the rubber stopper of the BAC water and inject the air into the vial

Design considerations to minimize the impact of drug absorption in polymer-based organ-on-a-chip platforms